IRM Energy and Piramal Pharma Surge Despite Market Downturn Global market declines and falling crude oil prices led to a significant drop in stock indices on Thursday, with the Sensex falling below 78,000 and the Nifty 50 slipping below 24,200. However, IRM Energy and Piramal Pharma shares defied the broader market weakness, posting sharp gains that attracted investor attention. IRM Energy’s shares rose over 15%, while Piramal Pharma’s shares surged more than 7%, marking a stark contrast to the overall market slump. The market downturn was driven by a surge in crude oil prices above $100 per barrel and weakness in Asian markets, which pressured investor sentiment. Despite these challenges, IRM Energy and Piramal Pharma emerged as standout performers. IRM Energy, a small-cap energy company, saw its shares trade at a record volume of over 3 crore on the NSE, reflecting heightened investor interest. Piramal Pharma’s shares also recorded a high trading volume of 3.10 crore, the highest since March 2025, ahead of its upcoming quarterly and annual results on April 28. IRM Energy, which operates as a city gas distribution (CGD) company, has seen its valuation shift from “expensive” in January 2026 to “fair” by April 2026. Its P/E ratio ranged between 19.30 and 21.60, with analysts rating it a “BUY” and setting a 12-month target price of ₹402.00. The company holds a monopoly in its geographic area for compressed natural gas (CNG) and piped natural gas (PNG) supply and is largely tax-free. However, its return on equity (ROE) remains low at 4-7%, and a zero PEG ratio raises concerns about growth potential. Piramal Pharma, a key player in the pharmaceutical sector, has attracted strong analyst confidence, with a “Strong Buy” rating and a 12-month target price range of ₹200-₹228, indicating potential for over 30% gains.#sensex #nifty_50 #nse #irm_energy #piramal_pharma
